# Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

> **NCT00543335** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Sorafenib
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00543335
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01-25
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Lack of Accrual.
- **Last updated:** 2018-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543335, "Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00543335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*